1. Home
  2. QNRX vs DTSS Comparison

QNRX vs DTSS Comparison

Compare QNRX & DTSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quoin Pharmaceuticals Ltd.

QNRX

Quoin Pharmaceuticals Ltd.

HOLD

Current Price

$12.25

Market Cap

10.1M

Sector

Health Care

ML Signal

HOLD

Logo Datasea Inc.

DTSS

Datasea Inc.

N/A

Current Price

$1.21

Market Cap

10.9M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
QNRX
DTSS
Founded
2018
2014
Country
United States
China
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
10.1M
10.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
QNRX
DTSS
Price
$12.25
$1.21
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
154.3K
60.6K
Earning Date
11-06-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$64,349,277.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
68.56
52 Week Low
$5.01
$1.03
52 Week High
$41.80
$3.10

Technical Indicators

Market Signals
Indicator
QNRX
DTSS
Relative Strength Index (RSI) 42.32 36.31
Support Level $11.48 $1.08
Resistance Level $15.45 $1.29
Average True Range (ATR) 2.60 0.12
MACD -1.05 0.02
Stochastic Oscillator 11.54 47.29

Price Performance

Historical Comparison
QNRX
DTSS

About QNRX Quoin Pharmaceuticals Ltd.

Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

About DTSS Datasea Inc.

Datasea Inc is a technology company that operates in two main segments. The first segment, Acoustic High-Tech, focuses on developing and applying acoustic technologies, such as ultrasound, infrasound, and mechanical wave effects, for applications like ultrasonic sterilization, neuro-regulation, acupoint stimulation, and environmental purification. The second segment, AI Multimodal Digitalization, integrates artificial intelligence with 5G networks and big data processing to create a proprietary multimodal data platform that combines text, voice, image, and video for real-time intelligent analysis and generation. The company generates all of its revenue from the People's Republic of China (PRC).

Share on Social Networks: